2-{[4-(2-Methoxyphenyl)piperazin-1-yl]methyl}-8-(4-nitrobenzenesulfonyl)-1,4-dioxa-8-azaspiro[4.5]decane

ID: ALA3342870

PubChem CID: 118716717

Max Phase: Preclinical

Molecular Formula: C25H32N4O7S

Molecular Weight: 532.62

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)O2)CC1

Standard InChI:  InChI=1S/C25H32N4O7S/c1-34-24-5-3-2-4-23(24)27-16-14-26(15-17-27)18-21-19-35-25(36-21)10-12-28(13-11-25)37(32,33)22-8-6-20(7-9-22)29(30)31/h2-9,21H,10-19H2,1H3

Standard InChI Key:  KTBIQCRMHWZGGG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   15.8279  -25.0770    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2406  -25.7869    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.6491  -25.0746    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.3334  -27.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5233  -27.8684    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3408  -27.9330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6578  -27.1794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0335  -26.6450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9384  -26.2129    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9171  -27.0339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6158  -27.4607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3567  -26.2496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6583  -25.8186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7715  -28.6342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5925  -28.6134    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0148  -29.3144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8323  -29.2957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2307  -28.5754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8013  -27.8723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9776  -27.8896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0487  -28.5565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4720  -29.2609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2924  -29.2436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6905  -28.5225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2581  -27.8174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4391  -27.8382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0134  -27.1366    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4046  -26.4191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5234  -26.1786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8299  -25.7514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1130  -26.1420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0928  -26.9599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7954  -27.3854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5094  -26.9923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3747  -27.3562    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3560  -28.1732    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6766  -26.9315    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  9 10  1  0
  9 13  1  0
 10 11  1  0
 11  4  1  0
  4 12  1  0
 12 13  1  0
  6 14  1  0
 14 15  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 18 21  1  0
 26 27  1  0
 27 28  1  0
  9  2  1  0
  2 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 35 36  2  0
 35 37  1  0
 32 35  1  0
M  CHG  2  35   1  37  -1
M  END

Alternative Forms

  1. Parent:

    ALA3342870

    ---

Associated Targets(Human)

ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra1d Alpha-1d adrenergic receptor (1475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 532.62Molecular Weight (Monoisotopic): 532.1992AlogP: 2.32#Rotatable Bonds: 7
Polar Surface Area: 114.69Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.32CX LogP: 3.29CX LogD: 3.03
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.39Np Likeness Score: -1.39

References

1. Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L..  (2014)  Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors.,  87  [PMID:25261823] [10.1016/j.ejmech.2014.09.070]

Source